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ABSTRACT 
 
EFFECTS OF PALMITIC ACID ON MILK PRODUCTION AND INSULIN SENSITIVITY  
IN MID-LACTATION DAIRY COWS. 
 
 
Alice Mathews 
 
This masters of science research evaluates the effects of palmitic acid (C16:0) 
supplementation on milk production and insulin sensitivity in mid-lactation dairy cows. The 
ability of saturated fatty acids (SFA) to enhance milk yield in dairy cows may be due to shifts in 
glucose utilization caused by reduced insulin sensitivity in adipose tissue. Our objective was to 
evaluate the effects of palmitic acid (C16:0) on milk production and insulin sensitivity in cows. 
Twenty multiparous mid-lactation Holstein cows were enrolled in a study consisting of a 5 d 
covariate, 49 d treatment, and 14 d post-treatment period. All cows received a common sorghum 
silage-based diet and were randomly assigned to a diet containing no supplemental fat (control; n 
= 10; 138 ± 45 DIM) or C16:0 at 4% of ration DM (PALM; 98% C16:0; n = 10; 136 ± 44 DIM). 
Blood and milk were collected at routine intervals. Intravenous glucose tolerance tests (300 
mg/kg of body weight (BW); GTT) were performed at d -1, 21, and 49 relative to start of 
treatment. Data were analyzed as repeated measures using a mixed model with fixed effects of 
treatment and time, and milk yield served as a covariate. PALM increased milk yield, energy-
corrected milk (ECM), and milk fat yield at wk 3, responses that were maintained at wk 7. 
Furthermore, PALM increased protein yield at wk 7. Changes in milk production occurred in 
parallel with enhanced energy intake and improved feed efficiency (ECM/dry matter intake). 
Enhanced milk fat yield during PALM treatment was due to increased C16:0 and C16:1 
incorporation. Supplementation of PALM had no effect on concentration of milk components, 
BW, or body condition score. Two weeks post-treatment, ECM and milk fat yield remained 
elevated in PALM-fed cows while yields of milk were similar between treatments. The 
concentration of non-esterified fatty acids (NEFA) in plasma increased by d 4, 6, and 8 of PALM 
treatment, a response not observed thereafter. Although PALM supplementation did not modify 
insulin, glucose, or triacylglycerol levels in plasma, total cholesterol in plasma was elevated by 
wk 3. Estimated insulin sensitivity was lower during the first week of PALM treatment; 
however, glucose disposal following GTT was not modified. In contrast, PALM feeding reduced 
glucose-stimulated NEFA disappearance by wk 7. Results demonstrate that increasing dietary 
energy from C16:0 for a 7 wk duration improves milk yield and milk composition without 
modifying systemic glucose tolerance. Reduced glucose-stimulated NEFA disappearance with 
PALM supplementation and elevated circulating NEFA may reflect changes in adipose tissue 
insulin sensitivity.  
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Chapter 1 
 
INTRODUCTION 
 
The onset of lactation involves homeorhetic adaptations in energy metabolism to divert 
nutrients to the mammary gland to support milk production (Bauman and Currie, 1980; 
Drackley, 1999). Specifically, the early lactation cow will develop insulin resistance in adipose 
and skeletal muscle tissues (Bell and Bauman, 1997). As a consequence, glucose is partitioned 
away from these tissues and toward the mammary gland to support lactose synthesis, the major 
osmotic regulator of milk volume (Walstra, 2013). Because insulin is an antilipolytic hormone, 
insulin resistance enhances adipose tissue lipolysis to partition NEFA toward peripheral tissues 
for β-oxidation and the mammary gland for re-esterification (Drackley et al., 2010). Although 
insulin resistance does not appear to develop in liver (Zachut et al., 2013), the peripartal dairy 
cow will experience an increase in hepatic gluconeogenesis to maintain homeostasis (Drackley et 
al., 2010). Collectively, these coordinated shifts in metabolism provide the mammary gland with 
necessary energy during the onset of lactation when energy intake is insufficient to meet 
metabolic demand. Beyond peak milk yield, insulin sensitivity in the cow increases, adipose 
tissue lipogenesis is favored (Mashek et al., 2001), and nutrients are partitioned toward the 
growing fetus (Bauman and Currie, 1980). As a consequence, milk yield gradually declines as 
the cow advances toward late lactation (McNamara and Hillers, 1986). 
As a means to enhance milk production during mid- and late-lactation, dairy producers 
supplement dairy cow rations with high-energy fat sources that can vary in saturation and acyl-
chain length (Drackley, 2004). Unsaturated fatty acid (UFA) supplements are toxic to many 
fiber-fermenting rumen microbes because they disrupt membrane function (Drackley, 2004; 
Jenkins, 1993). Therefore, UFA undergo ruminal biohydrogenation to become saturated 
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(Drackley, 2004). Biohydrogenation can decrease dry matter intake (DMI) (Kirovski et al., 
2015), inhibit milk fat synthesis, and decrease milk production (Drackley, 2004). In contrast, 
saturated fatty acid (SFA) supplements can bypass rumen biohydrogenation are absorbed by the 
intestinal epithelium intact, and the production responses to SFA supplementation are favorable 
(Drackley, 2004). For instance, increasing SFA intake in dairy cows can increase feed efficiency, 
milk yield, and milk fat yield (Wang et al., 2010), while having little effect on DMI (Allen, 2000; 
Loften et al., 2014). Furthermore, production responses are dependent upon chain length of the 
SFA. Previous research shows that when lactating cows are supplemented with either stearic acid 
(C18:0) or C16:0, milk and fat yield are significantly higher in the C16:0-fed cows (Rico et al., 
2014b). Although production responses have been characterized, the mechanism through which 
C16:0 increases in milk fat yield remains unknown.  
Though SFA feeding appears to alter metabolic status, few studies have made this the 
focus of their research, instead concentrating on production responses (Piantoni et al., 2013; Rico 
et al., 2014b). Available data on metabolism indicates that in addition to increased milk and fat 
yield observed in response to SFA, dairy cows exhibit elevated circulating NEFA (Piantoni et al., 
2013; Rico et al., 2014b), insulin (Piantoni et al., 2013) and glucose (Rico et al., 2014b). 
Furthermore, there is a relationship between concentration of circulating NEFA and insulin 
resistance in ruminants (De Koster and Opsomer, 2013). Recently, Pires et al. (2007) discovered 
that the infusion of tallow to dry cows induces insulin resistance and decreases glucose tolerance. 
However, whether elevations in circulating SFA play a role in causing insulin resistance in mid-
lactation dairy cows remains unclear. 
In contrast to ruminants, the relationship between SFA intake and the development of 
insulin resistance is well established in monogastrics (Larsen and Tennagels, 2014). Monogastric 
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insulin resistance is partly due to C16:0-stimulated increases in de novo synthesis of sphingolipid 
ceramide, which directly antagonize the insulin signaling pathway in muscle, adipose, and liver 
tissues (Funaki, 2009; DeFronzo, 2010; Larsen and Tennagels, 2014). This occurs through 
blocking phosphorylation of protein kinase B (Akt) in the insulin signaling pathway, preventing 
glucose transporter 4 (GLUT4) translocation to the plasma membrane (Larsen and Tennagels, 
2014).  Current evidence suggests mechanistic similarities in ruminants and monogastrics in 
SFA-induced insulin resistance. Because the majority of research surrounding C16:0 
supplementation emphasizes production responses, giving minimal attention to changes in 
metabolism, the focus of this thesis is to evaluate the effects of C16:0 feeding on changes in milk 
yield and components, and how these are associated with insulin sensitivity in mid-lactation 
dairy cows. 
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Chapter 2 
 
LITERATURE REVIEW 
Energy metabolism during lactation 
Early lactation dairy cattle experience a suppression in appetite and increased energy 
demand to support the production of milk (Bauman and Currie, 1980; Bell, 1995; Bell and 
Bauman, 1997). To meet the metabolic demand of lactation, the dairy cow must develop 
homeorhetic adaptations to partition nutrients to the mammary gland (Bauman and Currie, 1980; 
Bell, 1995). The mammary gland requires up to 80% of the glucose turnover in the cow during 
early lactation (Bauman and Currie, 1980). Because of the increase in mammary gland glucose 
uptake, the early lactation cow will experience an increase in gluconeogenesis and 
glycogenolysis as an attempt to maintain glucose homeostasis (Bauman and Currie, 1980). 
Furthermore, the early lactation cow experiencing negative energy balance (NEB) will mobilize 
NEFA from adipose tissue triacylglycerol (TAG) and amino acids (AA) from skeletal muscle 
protein (Bauman and Currie, 1980). To facilitate nutrient partitioning to the mammary gland, 
adipose and skeletal muscle tissues will develop insulin resistance during early lactation (Bell 
and Bauman, 1997). The mammary gland, which is unresponsive to insulin, will utilize glucose, 
NEFA, and AA to synthesize milk lactose, TAG, and protein, respectively (Bauman and Currie, 
1980). Beyond peak milk yield, the mid-lactation dairy cow will experience a gradual decline in 
milk production with the restoration of positive energy balance (McNamara and Hillers, 1986). 
Occurring in parallel, nutrient partitioning will be diverted away from the mammary gland and 
toward the growing fetus (Bauman and Currie, 1980). Furthermore, insulin sensitivity improves 
to favor adipose tissue lipogenesis and skeletal muscle protein accretion (McNamara and Hillers, 
1986).  
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Carbohydrate metabolism 
In a typical commercial dairy ration, sources of carbohydrates are in the form of 
nonstructural or structural carbohydrates (NRC, 2001). Nonstructural carbohydrates include 
sugars and starch, and are highly digestible compared with structural carbohydrates cellulose, 
hemicellulose, and lignin (Nafikov and Beitz, 2007). Nutritionists evaluate dietary structural 
carbohydrate availability by measuring neutral detergent fiber (NDF; cellulose, hemicellulose, 
and lignin) as well as acid detergent fiber (ADF; lignin and cellulose) (Nafikov and Beitz, 2007). 
The recommended NDF concentration for early- and mid-lactation dairy cows is approximately 
30% of diet dry matter, with at least 75% of that NDF being from forage (NRC, 2001). 
Additionally, the concentration of nonfermentable carbohydrates should be 35-38% of the diet 
(NRC, 2001). Formulating dairy cow rations to have a correct percentage of fiber and 
carbohydrates is critical for a steady rumen pH to reduce the risk of rumen acidosis and maintain 
the rate of volatile fatty acid (VFA) absorption (NRC, 2001). 
The availability of dietary structural and nonstructural carbohydrates can influence 
microbial fermentation and VFA production. Volatile fatty acids are short chain fatty acids 
(SCFA) produced by rumen microbes that serve as essential energy sources for the ruminant 
animal (Bergman, 1990; Nafikov and Beitz, 2007).  The primary rumen-derived VFA include 
acetate (2C), propionate (3C), and butyrate (4C) (Bergman, 1990; van Houtert, 1993). Upon 
entry into the small intestine, VFA are absorbed through the intestinal epithelium and enter 
hepatic portal circulation (Bergman, 1990). Acetate is a source of energy due to its contribution 
to the citric acid cycle, and also a major contributor of acetyl-coenzyme A (CoA) for lipid 
synthesis in tissues such as adipose and mammary gland (Armentano, 1992). Additionally, 
butyrate is a major carbon supplier for adipose tissue and mammary gland lipogenesis (Bergman, 
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1990), and propionate is a primary contributor to hepatic gluconeogenesis (Nafikov and Beitz, 
2007). Diet affects the profile of VFA in the rumen. Intake of rich grasses increases acetate 
production, forage and concentrate increases butyrate, and starch and cereal grain intake elevates 
propionate production. Furthermore, UFA supplements can affect VFA production due to 
toxicity to fiber-fermenting microbes (Jenkins, 1993). Unsaturated FA partition lipids into the 
microbial cell membrane, disrupting membrane cell function and expression of hydrolytic 
enzymes (Jenkins, 1993). Because of these effects, UFA undergo ruminal biohydrogenation to 
become SFA (Drackley, 2004). In contrast, feeding SFA has little effect on VFA production, and 
are directly absorbed into the intestinal epithelium and can be utilized for energy. 
Dairy cows cannot meet their demands for glucose through diet alone because ruminant 
absorption of glucose is minimal (Amaral et al., 1990). To meet the homeostatic demands for 
circulating glucose, the dairy cow will continually rely on gluconeogenesis (Drackley et al., 
2001). The dairy cow synthesizes glucose in liver and kidneys; however, hepatic 
gluconeogenesis contributes approximately 90% of the total glucose requirement for the animal 
(Amaral et al., 1990). For instance, a dairy cow that produces 90 kg/d of milk requires 7.4 kg/d 
of glucose, with 6.6 kg of glucose derived from gluconeogenesis (Amaral et al., 1990). To meet 
the metabolic demand, dairy cows require glucose precursors such as propionate, lactate, alanine 
and glycerol (Drackley et al., 2001; Aschenbach et al., 2010).  
The rumen-derived VFA propionate is considered the predominant substrate for 
gluconeogenesis in ruminants (Amaral et al., 1990; Aschenbach et al., 2010). Hepatic propionate 
metabolism involves conversion to oxaloacetate (OAA), a key point of entry for most 
gluconeogenic substrates into gluconeogenesis (Aschenbach et al., 2010). The OAA can either 
be metabolized to form glucose through phosphoenolpyruvate (PEPCK) and glucose-6-
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phosphatase, or can serve as an acetyl-CoA acceptor in the citric acid cycle to form citrate 
(Wiltrout and Satter, 1971; Barthel and Schmoll, 2003; Aschenbach et al., 2010). In addition to 
propionate, cytosolic lactate, derived from either microbial fermentation of starch or glucose 
catabolism by peripheral tissues, is a second precursor for OAA and subsequently 
gluconeogenesis (Drackley et al., 2001; Aschenbach et al., 2010). Additionally, lactate-derived 
glucose can be conserved through use of the Cori cycle, which recycles glucose and lactate 
between the liver and muscle (Baird et al., 1983). A third contributor to gluconeogenesis are the 
glucogenic AA alanine and glutamine, which are deaminated to yield pyruvate for 
gluconeogenesis (Aschenbach et al., 2010). Together, alanine and glutamine account for 40 to 
60% of the glucogenic potential of all AA (Drackley et al., 2001). When the cow is in a catabolic 
state, the animal will mobilize NEFA and glycerol from adipose tissue (Drackley et al., 2001). 
As the cow adapts to lactation, glycerol can be used as a precursor for gluconeogenesis, however 
only 2 to 5% of total glucose comes from glycerol (Drackley et al., 2001; Aschenbach et al., 
2010). Although glycerol can be used to support gluconeogenesis, fatty acids cannot due to the 
irreversibility of pyruvate to acetyl CoA (Tirone and Brunicardi, 2001). In addition to 
gluconeogenesis, the catabolic dairy cow can rely on glycogenolysis activated by adenylate 
cyclase during periods of elevated glucose demand (Tirone and Brunicardi, 2001). 
Disadvantageously, the supply and storage of glycogen is limited during early lactation (Herdt, 
2000). 
Main regulators of gluconeogenesis and glycogen metabolism include pancreatic insulin 
and glucagon (Tirone and Brunicardi, 2001). During early lactation, cows are in a catabolic state 
and are resistant to insulin, allowing glucagon to upregulate glucose synthesis for increased 
mammary uptake (Bell and Bauman, 1997; Barthel and Schmoll, 2003).  Glucagon will increase 
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the rate of gluconeogenesis in part by increasing intracellular cyclic adenosine monophosphate 
(cAMP) (Tirone and Brunicardi, 2001) and stimulating glucose-6-phosphatase and PEPCK 
(Barthel and Schmoll, 2003). Following peak milk yield, glucagon levels decline and insulin 
levels rise. As a consequence, insulin downregulates hepatic gluconeogenesis by reducing cAMP 
availability, and increasing glycogen storage in liver and skeletal muscle tissues (Herdt, 2000; 
Barthel and Schmoll, 2003). 
The mechanism of cellular glucose uptake varies depending on the cell type (Lohrenz et 
al., 2011). Dietary-derived glucose is absorbed in the small intestine through mediation of 
sodium-dependent glucose transporters (SGLT) within intestinal epithelial cells, or glucose 
transporter (GLUT) in the apical membrane of enterocytes (Lohrenz et al., 2011; Zheng et al., 
2012). In the intestine the uptake of glucose through SGLT is driven by a difference in the 
sodium concentration gradient. In contrast to SGLT, intestinal GLUT2 is a low-affinity, high-
capacity facilitated transporter (Zheng et al., 2012). Peripheral tissue uptake of dietary and de 
novo synthesized glucose occurs via various GLUT isoforms in all tissues except the kidney 
(Tirone and Brunicardi, 2001). Five GLUT transporters have been identified, which can be 
sensitive or insensitive to insulin. Liver and pancreatic beta cells contain GLUT2, which is 
insulin independent, allowing hepatocytes and beta cells to act as glucose sensors (Tirone and 
Brunicardi, 2001). As glucose levels in the blood increase, the pancreatic beta cells respond by 
producing and secreting more insulin, and hepatocytes respond by decreasing hepatic 
gluconeogenesis (Tirone and Brunicardi, 2001). The bovine mammary gland contains insulin-
insensitive GLUT1 (Zhao et al., 1996). Muscle and adipose tissues contain GLUT4, which is an 
insulin-dependent transporter, meaning that adipose and muscle tissues are susceptible to insulin 
resistance (Zhao et al., 1996). In adipose and muscle, insulin action can increase GLUT4 
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translocation to the plasma membrane upon activation of protein kinase B (Akt) (Zeng et al., 
2000; Tirone and Brunicardi, 2001). 
Lipid metabolism 
Lipid content in the diet of a ruminant is primarily composed of TAG followed by 
glycolipids, phospholipids, and NEFA (Drackley, 2004). Although NEFA are not a major 
component of a dairy cow ration they are the main ingredient in most purified fat supplements 
(Drackley, 2004). Fat supplements can be either UFA or SFA, however UFA are toxic to many 
species of rumen microbes (Jenkins, 1993; Palmquist, 2006). Typically 90% of dietary UFA will 
be hydrogenated to SFA before absorption in the small intestine (Drackley, 2004; Palmquist, 
2006). Conversely, supplemental non-esterified SFA will be directly absorbed as NEFA 
(Palmquist, 2006), and SFA are the main type of fatty acid that reaches the small intestine for 
absorption (Drackley, 2004).  
Within the enterocyte of the small intestine, 80-90% of lipids are NEFA, and when no 
supplemental fat is added, C18:0 and C16:0 are the primary intracellular fatty acids (Drackley, 
2004). In the small intestine, NEFA are incorporated into luminal micelles which are bi-layer 
disks that consist of bile salts and phospholipids. Micelle fatty acids are absorbed in the small 
intestine via the action of the emulsifier lysolecithin, an efficient emulsifier for SFA (Drackley, 
2004; Palmquist, 2006). After absorption, fatty acids are esterified to glycerol forming TAG 
within the enterocyte. Enterocyte TAG are packaged into chylomicrons in combination with 
cholesterol, phospholipids, and apoproteins needed for transport (Drackley, 2004). The TAG-
containing chylomicrons are secreted into the lymph and travel to peripheral tissues where lipids 
are utilized through the action of lipoprotein lipase (LPL) (Drackley, 2004). The fate of fatty 
acids varies depending on the energy status of the cell. In the mammary gland, fatty acids can be 
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formed back into TAG to support milk fat synthesis, or can be oxidized to increase ATP supply 
(Drackley, 2004). In adipose tissue, fatty acids can be either stored as TAG or mobilized as 
NEFA to be utilized by peripheral tissues (Rasmussen and Wolfe, 1999). Additionally, in the 
liver, fatty acids can be either stored as TAG, or oxidized for eventual ATP or ketone production. 
Finally, in skeletal muscle, fatty acids are oxidized and utilized as an energy source (Rasmussen 
and Wolfe, 1999). In ruminants, the majority of dietary fat will be utilized for TAG synthesis in 
the mammary gland or adipose tissue depending on the state of energy balance (Drackley, 2004). 
During early lactation, the cow will experience decreased lipogenesis and enhanced 
lipolysis in adipose tissue, partly due to the induction of insulin resistance (Bell and Bauman, 
1997). Approximately half of the mobilized NEFA are utilized for energy or ketone production 
or taken up by the mammary gland and re-esterified for incorporation into milk fat (Bell, 1995; 
Barthel and Schmoll, 2003). During mid-lactation, the anabolic dairy cow will experience a 
restoration in insulin sensitivity and a subsequent increase in insulin-stimulated adipose tissue 
lipogenesis and suppressed lipoysis (Drackley et al., 2001; Nafikov and Beitz, 2007; Laliotis et 
al., 2010).  
Protein metabolism 
Dairy cows require AA for maintenance, growth, and milk production. Necessary protein 
comes from the diet in the form of rumen undegradable protein (Bremmer et al., 1998) or from 
protein synthesized by microbes in the rumen (NRC, 2001). A high producing dairy cow should 
receive approximately 16% of DM as crude protein to support milk production, and lysine and 
methionine are critical dietary components because they are the first limiting AA (NRC, 2001). 
Not all crude protein provided to cows is available for intestinal absorption. Therefore, protein is 
further categorized into metabolizable protein which can be in the form of rumen degradable 
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protein (RDP) or RUP (Bremmer et al., 1998; NRC, 2001; Hopkins and Whitlow, 2015). Both 
dietary RUP and RDP are required for milk protein synthesis. In the rumen, microbes breakdown 
RDP to release ammonia, and through the use of carbohydrates and ammonia the microbes 
synthesize proteins that are utilized by the animal (Hopkins and Whitlow, 2015). Excess 
ammonia is absorbed through the rumen and metabolized to urea in the liver (Hopkins and 
Whitlow, 2015). Hepatic urea can either circulate back to the rumen via saliva or be excreted in 
urine (Hopkins and Whitlow, 2015). Concentrations of rumen urea are measured through blood 
urea nitrogen or milk urea nitrogen (MUN) (Hopkins and Whitlow, 2015). Levels of MUN above 
18 mg/dL indicate that a producer is either overfeeding RDP or underfeeding fermentable 
carbohydrates (Hopkins and Whitlow, 2015). In addition to dietary and microbial protein 
requirements of lactating cattle, modifications to protein metabolism occur during times of NEB 
(Bauman and Currie, 1980). The main homeorhetic adaptation in protein metabolism in dairy 
cattle is increased mobilization of AA from skeletal muscle to support hepatic gluconeogenesis 
and milk protein synthesis (Bauman and Currie, 1980; Bell, 1995).  
Mammary gland biology 
Lactogenesis and galactopoiesis  
Lactogenesis is defined as the induction of milk synthesis, whereby the mammary gland 
alveolar cells are stimulated to secrete milk, a response that occurs after mammogenesis as 
parturition approaches (Neville et al., 2002). The first stage of lactogenesis ensues before 
parturition and involves differentiation of alveolar cells and limited secretion of milk (Husveth, 
2011). Second, at parturition, the mammary gland responds to insulin, glucocorticoids, and 
prolactin to initiate milk synthesis (Husveth, 2011). Glucocorticoids are required for milk 
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secretion, and are critical for transcription of casein and α-lactalbumin (NRC, 1988). Near 
parturition, increased glucocorticoid receptor number causes elevated uptake of glucocorticoids 
by the mammary gland (NRC, 1988). In addition to glucocorticoids, prolactin is critical for 
lactogenesis (Neville et al., 2002). In the presence of insulin and glucocorticoids, prolactin 
initiates lactation, milk secretion and lactose and casein production (Husveth, 2011). The role of 
insulin in lactogenesis remains fairly elusive, although in vitro studies reveal that it may also be 
required for mammary cell differentiation in early lactogenesis (Howlett and Bissell, 1990).  
Upon initiation of lactogenesis, prostaglandin F2 stimulates the corpus luteum to regress 
causing progesterone to decrease (Husveth, 2011).  Normally, progesterone suppresses 
lactogenesis by inhibiting the action of prolactin causing downregulation of lactose synthetase, 
as well as the transcription, stabilization, and translation of messenger RNA (mRNA) for milk 
proteins (Husveth, 2011). When progesterone levels decline, glucocorticoid levels increase 
stimulating prolactin secretion from the anterior pituitary gland (Husveth, 2011). After exposure 
to the hormones prolactin, insulin, and glucocorticoids, the mammary secretory cells differentiate 
and development of the endoplasmic reticulum and Golgi apparatus assists in mammary 
synthesis of protein, fat, and lactose for milk (Neville and Morton, 2001; Husveth, 2011). 
Galactopoiesis is defined as maintenance of lactation and depends on the removal of milk 
from the mammary gland (Husveth, 2011). Hormones such as growth hormone, insulin–like 
growth factor (IGF-1), thyroid stimulating hormone, insulin, parathyroid hormone, oxytocin, as 
well as the feedback inhibitor of lactation (FIL) protein are all involved in maintenance of 
lactation (Neville et al., 2002). Growth hormone and IGF-1 maintain mammary epithelial cell 
number for sustained milk production (Baumrucker, 1986). In addition to growth factors 
maintaining cell number for milk production, oxytocin is required for milk discharge (Neville et 
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al., 2002). Upon milking stimulation of the mammary teats, oxytocin is released into circulation 
from the neural lobe of the pituitary, and binds to receptors on myoepithelial cells surrounding 
the alveoli, inducing their contraction causing expulsion of milk through the ductules into the 
cistern (Lollivier and Marnet, 2005). Furthermore, frequent removal of milk maintains milk 
production by removing FIL protein which normally inhibits milk secretion through inhibiting 
mammary differentiation (Bar-Pelled et al., 1995). Without frequent milk removal, milk 
synthesis will be inhibited due in part to an accumulation of FIL (Bar-Pelled et al., 1995).  
Milk component synthesis  
The disaccharide lactose, composed of a glucose and a galactose unit, is the major 
osmotic regulator of milk volume and is consistently 5% of milk (Mellenberger et al., 1973). 
Glucose is taken up by the mammary gland through GLUT1 where it is converted to UDP-
glucose and ultimately UDP-galactose through the action of UDP-galactose-4-epimerase. Along 
with a glucose unit, the newly formed galactose is used for lactose synthesis through the action 
of lactose synthase, composed of α-lactalbumin and galactosyltransferase (Mellenberger et al., 
1973).  
In addition to lactose, protein is a major component of milk and its concentration is 
normally around 3.5% of milk (Bionaz et al., 2012). The main proteins in milk are caseins and 
whey proteins, however there are over 100 proteins in milk (Bionaz et al., 2012). The mammary 
gland requires up to 275 g/d of circulating AA for milk protein synthesis, and the AA are derived 
from either dietary RUP, rumen microbe-derived protein, or mobilized AA from skeletal muscle 
tissue (Hopkins and Whitlow, 2015). Furthermore, milk protein content can be altered by 
availability of dietary energy (Bauman and Currie, 1980; Reynolds et al., 1994). Increased 
energy in the form of concentrates or fat supplements are associated with increased protein in 
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milk (Reynolds et al., 1994). This is thought to be due to a greater availability of energetic 
precursors such as nicotinamide adenine dinucleotide phosphate (NADPH) as well as 
metabolizable energy because of a decrease in fat synthesis in the mammary gland during 
supplementation of fats (Bionaz et al., 2012). In addition to dietary energy content, availability of 
circulating AA affect magnitude of milk protein synthesis (Rius et al., 2010; Bionaz et al., 2012). 
As uptake of AA increase, flux through mammalian target of rapamycin (mTOR) in the 
mammary gland is enhanced, which stimulates greater utilization of AA for protein synthesis in 
the mammary gland (Rius et al., 2010). Additionally, insulin is thought to play an important role 
in milk protein synthesis. Although the mechanism remains elusive, the pattern of insulinemia 
during lactation closely follows the pattern of milk protein concentration (Bionaz et al., 2012). 
In addition to lactose and protein, milk fat is an important, yet variable component in 
milk, and is usually around 4% of milk. The most predominant lipids in milk are TAG, followed 
by diacylglycerol (DAG) and small amounts of other lipids such as phospholipids and 
cholesterol (Barber et al., 1997; Månsson, 2008). There are estimated to be up to 400 different 
esterified fatty acids in bovine milk (Jensen, 2002), their origin being dietary, mobilized NEFA, 
or de novo synthesis in the mammary gland (Palmquist, 2006). When no supplemental fat is 
added to a dairy cow ration, approximately 50% of milk fat is derived from de novo synthesis in 
the mammary gland, while 50% is taken up from circulation (Linn, 1988; Månsson, 2008; 
Palmquist, 2006).  
Within the mammary epithelial cells, fatty acids from C4 to C16 are synthesized de novo 
using ruminally derived acetate and butyrate, although C16:0 is derived from either de novo 
synthesis or circulation (Enjalbert et al., 1998; Palmquist, 2006). The principle precursor of de 
novo synthesis of FA in the mammary gland is acetate. Briefly, acetate is converted to acetyl-
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CoA through acyl-CoA synthetase, and to malonyl-CoA through the rate-limiting enzyme acetyl-
CoA carboxylase-α (ACC), which is activated by sterol element binding protein-1 (Nafikov and 
Beitz, 2007; Palmquist, 2006). The enzyme fatty acid synthase catalyzes the elongation of fatty 
acids and requires rumen-derived butyrate or acetate, and NADPH (Laliotis et al., 2010). In 
ruminants, NADPH is generated mainly through isocitrate dehydrogenase which produces 
NADPH through the conversion of isocitrate to α-ketoglutarate. Additional NADPH is provided 
through the pentose phosphate pathway (PPP) (Laliotis et al., 2010; Nafikov and Beitz, 2007). 
Although citrate cleavage enzyme (ATP:citrate lyase) and malic enzyme (NADPH-malate 
dehydrogenase) provide additional NADPH for lipogenesis in monogastrics, activity of these 
enzymes are very low in ruminants, making this pathway insignificant for milk fat synthesis in 
dairy cows (Nafikov and Beitz, 2007). Lipogenesis of milk fatty acids ends when a thioesterase 
specific to the chain length produced releases the fatty acid from the enzyme complex 
(Palmquist, 2006).  
The main mediator of mammary gland uptake of circulating chylomicron-rich TAG is 
LPL (Palmquist, 2006). Mammary LPL is regulated in-part by prolactin in the anterior pituitary 
during lactation and is synthesized in the parenchymal cells of the mammary gland and located 
in the capillary wall (Barber et al., 1997; Palmquist, 1996). Lipoprotein lipase hydrolyzes TAG 
to form NEFA, glycerol, and 2-monoacylglycerol. Around parturition LPL increases and remains 
elevated in the mammary gland while being down-regulated in adipose tissue (Palmquist, 2006). 
Although LPL is a main contributor to mammary uptake of LCFA from circulation, Barber et al. 
(1997) suggested that the protein fatty acid translocator may also assist with the transport of 
LCFA across the mammary epithelial cell membrane, and fatty acid-binding protein is involved 
in this process. Furthermore, fatty acid-binding protein can be transcriptionally regulated by 
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LCFA through a mechanism involving peroxisomal proliferator-activated receptors (Barber et 
al., 1997).  
Milk fatty acids must be activated to their fatty-acyl CoA ester for TAG synthesis and 
incorporation into milk (Palmquist, 2006). The first committed step in TAG synthesis is the 
acylation of glycerol-3-phosphate, and the enzyme responsible for this reaction is glycerol 3-
phosphate acyltransferase (GPAT) (Coleman and Lee, 2004). The action of GPAT produces 
phosphatidic acid which is converted to DAG, which through DAG acyltransferase is converted 
to TAG (Coleman and Lee, 2004; Palmquist, 2006). Once formed, TAG are incorporated into 
lipid droplets in the endoplasmic reticulum and are released into the lumen for incorporation into 
milk (Linn, 1988). 
Fatty acid supplementation in dairy cows 
Various forms of fats can be found in a dairy cow ration. A typical ration mainly includes 
TAG because these are a major source of lipid in cereal grains, oilseeds, and byproduct feeds 
(Drackley, 2004), and are also the major lipid in milk fat (Palmquist, 2006). Additionally, 
glycolipids found in forages are a source of lipid in dairy cow rations, and these are completely 
broken down in the rumen to release fatty acids and glycerol (Drackley, 2004). Similar to NEFA, 
phospholipids are a minor component of most dairy rations. However, NEFA are a major 
component of most fat supplements when provided to dairy cows (Drackley, 2004). Free fatty 
acids are not attached to a glycerol molecule, but consist of a hydrocarbon chain of variable 
length and saturation. In dairy cows, C16:0 and C18:0 are the most common fatty acids found 
within NEFA supplements (Drackley, 2004). 
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Intake and feed efficiency 
Although supplemental fats increase the energy density of the diet, they have been found 
to decrease DMI. In a review by Allen (2000), fat supplements that differ in fatty acid source, 
form, and type have differing effects on DMI. Depression of DMI has been found in various 
studies when fat is supplemented, and this is thought to involve a negative effect on rumen 
fermentation or gut motility (Allen, 2000). Furthermore, Allen (2000) explains that as the 
concentration of calcium salts of palm FA supplementation increases, DMI decreases. 
Importantly, feeding fat to lactating cows can increase circulating cholecystokinin (CCK) (Choi 
and Palmquist, 1996), which not only stimulates digestion of fat and protein but also acts as a 
hunger suppressant in cows (Choi and Palmquist, 1996). Action of CCK on satiety signals either 
act directly from brain satiety centers, or from peripheral action of gut CCK involving gastric-
emptying inhibition as well as activation of neurons that inhibit satiety centers in the brain 
(Allen, 2000).  
Supplementation of dietary fats has resulted in a hyperphagic effect in few studies (Allen, 
2000; Mosley et al., 2007). However, it is known that UFA have a greater negative effect on 
DMI than SFA supplements (Onetti and Grummer, 2004). This may explain the decreased DMI 
observed in studies that utilize tallow as a fat supplement, since approximately 50% of fatty acid 
in tallow are unsaturated, consisting predominately of C18:1 (Onetti and Grummer, 2004). In 
addition to its effects on DMI, supplemental fat also influences feed efficiency in lactating dairy 
cows. Feed efficiency is defined as the ability of the cow to convert feed nutrients into milk and 
milk components and is normally measured using DMI and ECM or 3.5% fat-corrected milk 
(3.5% FCM), which corrects for the energy and fat content of milk, respectively (Maulfair et al., 
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2011). Studies have confirmed that SFA, particularly C16:0, supplementation to dairy cows 
increases both ECM and 3.5% FCM feed efficiency (Mosley et al., 2007; Piantoni et al., 2013).  
Milk yield and composition 
Typically, providing supplemental fat to lactating dairy cows increases milk and milk fat 
yield. A meta-analysis by Rabiee et al. (2012) found that supplementing dietary fat to lactating 
cows can increase milk yield by an average of 1.05 kg/d. Additionally, the response in milk fat 
percentage to SFA supplementation varies by type of supplement, but dietary SFA tend to 
increase milk fat percent (Mosley et al., 2007; Piantoni et al., 2013; Rabiee et al., 2012). 
Typically, fat supplements decrease milk protein percent, and have varying effects on protein 
yield. Limited experiments have observed decreased protein yield (Rabiee et al., 2012), while 
others observed an increased protein yield in milk with SFA supplementation (Wang et al., 
2010). Finally, feeding SFA increases ECM and 3.5% FCM, particularly with C16:0 feeding 
(Piantoni et al., 2013; Rico et al., 2014). 
Degree of saturation may contribute to the variety of milk production and composition 
responses associated with various fat supplements (Harvatine and Allen, 2005). For instance, 
UFA decrease DMI compared with SFA leading to decreased milk yield and components 
(Harvatine and Allen, 2005). Similarly, the more unsaturated a supplement, the greater decreases 
in milk fat concentration and yield are observed (Harvatine and Allen, 2005). 
Milk fatty acid composition 
Typical fatty acid composition in dairy cow milk consists of around 5% polyunsaturated 
fat (PUFA), 25% MUFA, and 75% SFA, and supplemental fat will change the profile of milk 
saturation (Grummer, 1991). Short-chain fatty acids are synthesized de novo in the mammary 
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gland, while most LCFA are taken up by the mammary gland through LPL and incorporated into 
milk fat (Drackley, 2004). When saturated fats such as C16:0 are supplemented to lactating dairy 
cows, concentration and yield of C16:0 increases in circulation (in the form of TAG-rich 
chylomicron), increasing availability for mammary uptake and incorporation of C16:0 into milk 
fat (Grummer, 1991). Increased incorporation of C16:0 into milk fat can decreases the 
incorporation of fatty acid such as C18:0, C18:1 cis-9, and SCFA in milk (Loften et al., 2014). 
The decrease in SCFA during C16:0 supplementation is thought to be due to an increase in 
concentration of LCFA availability for the mammary gland from circulation, a response 
associated with the deactivation of ACC, a rate limiting enzyme required for fatty acid synthesis 
(Loften et al., 2014). With this in mind, many studies that feed supplemental C16:0 often see 
decreased de novo synthesized fatty acid and the accumulation of butyrate (a primer for fatty 
acid synthase) in milk during supplementation (Glasser et al., 2008). In addition to fatty acid 
supplementation affecting milk fatty acid profiles, mammary desaturase activity increases 
variability of milk fat (Grummer, 1991). In the mammary gland, desaturases convert SFA to 
MUFA, which is thought to ensure fluidity of milk fat for secretion from the epithelial cell 
(Grummer, 1991). 
Metabolic responses 
The effects of supplementing fatty acids to lactating dairy cows on energy metabolism 
have not been widely examined. Data available shows that circulating NEFA is elevated in cows 
supplemented with SFA during lactation (Piantoni et al., 2013; Rico et al., 2014), and the 
concentration of NEFA is higher during C16:0 feeding compared to C18:0 supplementation 
(Rico et al., 2014). Once SFA greater than C12 are ingested, they are converted to their CoA 
derivatives and re-esterified to TAG after being absorbed in the small intestine (Bach and 
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Babayan, 1982), and subsequently packaged into chylomicron and hydrolyzed by LPL in tissues 
(Christie et al., 1986). Therefore, the elevated NEFA observed with SFA feeding could be in part 
due to dietary fatty acid intake. Additionally, few experiments have observed SFA supplements 
increasing the concentration of circulating glucose and insulin (Rico et al., 2014). When 
observed, increased circulating glucose is thought to be in part due to a decrease in SFA-induced 
insulin-regulated inhibition of hepatic gluconeogenesis (Funaki, 2009). Additionally, elevations 
in circulating insulin during dietary intake of SFA is thought to be associated with a decrease in 
insulin sensitivity in monogastric animals, thereby leading to elevated levels of plasma insulin 
(Funaki, 2009; Kennedy et al., 2008). The relationship between dietary intake of SFA and 
changes in insulin sensitivity requires further investigation. 
In contrast to NEFA, glucose, and insulin, limited data is available on the circulating 
levels of TAG and cholesterol during supplemental SFA feeding in ruminants. However, existing 
data shows that supplementing SFA to lactating cows has no effect on circulating TAG levels 
(Piantoni et al., 2013). Conversely, increased concentration of cholesterol in plasma is often 
observed in dairy cows on a SFA supplement (Bremmer et al., 1998; Andersen et al., 2008). 
Palmitic acid is considered hypercholesterolemic (Fernandez and West, 2005). Fernandez and 
West (2005) suggest that elevated cholesterol with C16:0 feeding may be due increased 
formation and reduced turnover of low-density lipoproteins. 
Mechanisms of insulin resistance 
During lactation, glucose utilization by the mammary gland is the metabolic priority in 
dairy cows (Bell and Bauman, 1997). To account for enhanced glucose uptake by the mammary 
gland, adipose and skeletal muscle tissues decrease glucose utilization. A review by Bell and 
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Bauman (1997) reveals that in order to spare glucose for lactose synthesis, adipose and skeletal 
muscle become resistant to the action of insulin and the liver increases the rate of 
gluconeogenesis. Adipose tissue insulin resistance leads to an increase in NEFA mobilization 
and decreased glucose use for lipogenesis (Bauman and Currie, 1980). The response of skeletal 
muscle to insulin resistance is an increase in AA mobilization, which is used for both hepatic 
gluconeogenesis and milk protein synthesis in the mammary gland (Bell and Bauman, 1997). 
Although induction of adipose and skeletal muscle insulin resistnance is recognized as a 
hallmark of the transition period, the cause of these changes remains elusive in dairy cows. 
However, research suggests impairment of proteins in the insulin signaling pathway downstream 
of phosphoinositol 3-kinase (Bell and Bauman, 1997; Zachut et al., 2013). 
In addition to homeorhetic adaptations to lactation causing insulin resistance, there is 
evidence of an association between fatty acids and insulin resistance in dairy cows. A review by 
De Koster and Opsomer (2013) details the associations between NEFA and severity of insulin 
resistance in dairy cows. Levels of circulating NEFA are negatively correlated with insulin-
stimulated glucose uptake when dairy cows undergo an insulin challenge (De Koster and 
Opsomer, 2013). Additionally, cows overfed during the dry period had elevated NEFA 
mobilization compared to lean cows, and a lower glucose clearance rate during a glucose 
challenge (De Koster and Opsomer, 2013). Finally, Rico et al. (2015) found that the level of 
NEFA in overweight cows correlates to severity of estimated insulin resistance during 
parturition. In addition to overweight cows displaying elevated insulin resistance, research 
suggests that dietary SFA decreases sensitivity to insulin (Pires et al., 2007). Recently, Pires et 
al. (2007) induced hyperlipidemia in dairy cows through intravenously infusing a tallow 
emulsion consisting of 25% C16:0. The tallow emulsion caused elevated NEFA, insulin, and 
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glucose, as well as decreased glucose tolerance, suggesting that fatty acids caused the cows to 
become less sensitive to insulin action (Pires et al., 2007). Although the mechanism of fatty acid-
induced insulin resistance in dairy cows has yet to be exposed, Pires et al. (2007) suggests that 
availability of SFA increases long-chain acyl-CoA and DAG that may interfere with insulin 
signaling. Additionally, Zachut et al. (2013) discovered that during a postpartmum glucose 
challenge, Akt phosphorylation was sustained in liver, implying sensitivity to insulin. However, 
Akt phosphorylation was diminished in adipose tissue during a glucose challenge, suggesting 
that adipose tissue insulin resistance and elevated lipolysis in lactating dairy cows is due in part 
to blocking insulin signaling pathway at Akt (Zachut et al., 2013). 
In monogastrics, elevated intake of SFA and elevated body fat are known to lead to 
accumulation of lipid mediators that antagonize insulin action and cause insulin resistance in 
liver, muscle, and adipose tissues (Barbour et al., 2007; DeFronzo, 2010). Specifically, it is 
accepted that in monogastrics, the toxic lipid mediator ceramide, which is upregulated by SFA, 
directly blocks phosphorylation of Akt in the insulin signaling pathway to cause insulin 
resistance (Larsen and Tennagels, 2014). The similarities between insulin resistance in 
monogastrics and ruminants suggests that ceramides may play a causal role in inducing insulin 
resistance in dairy cows by blocking Akt phosphorylation. Furthermore, enhanced NEFA 
mobilization and SFA intake may increase ceramide-induced insulin resistance in dairy cows.  
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Chapter 3 
 
INCREASING PALMITIC ACID INTAKE ENHANCES MILK PRODUCTION AND 
PREVENTS GLUCOSE-STIMULATED NEFA DISAPPEARANCE WITHOUT 
MODIFYING SYSTEMIC GLUCOSE TOLERANCE IN MID-LACTATION DAIRY 
COWS 
Introduction 
Dairy cows experience an elevated demand for circulating glucose at the onset of lactation due to 
an increased requirement by the mammary gland for lactose synthesis (Bell, 1995). As a means 
to partition glucose towards the mammary gland, early lactation cows will develop insulin 
resistance to decrease glucose uptake by skeletal muscle and adipose tissues (Bell and Bauman, 
1997; De Koster and Opsomer, 2013). Concomitantly, adipose tissue lipolysis will provide 
NEFA for β-oxidation in peripheral tissues and re-esterification in the mammary gland 
(McNamara and Hillers, 1986; Zachut et al., 2013). Because insulin is an anti-lipolytic hormone, 
insulin resistance can further facilitate the mobilization of NEFA from adipose tissue. These 
homeorhetic adaptations are characteristic metabolic shifts in energy metabolism unique to early 
lactation cows coping with energy insufficiency and experiencing rapid increases in milk 
production. As lactation progresses beyond peak daily milk yield, insulin-stimulated glucose 
uptake by peripheral tissues increases and circulating NEFA availability declines to minimal 
levels (McNamara and Hillers, 1986; Bell and Bauman, 1997). Furthermore, the restoration of 
positive energy balance is accompanied by the beginning of milk production decline. 
The supplementation of SFA is a nutritional management practice utilized by producers 
to increase the energy density of diets offered to cows during lactation. Feeding cows palmitic 
acid (C16:0) has been reported to improve feed efficiency (Rico et al., 2014a), and increase milk 
yield and milk fat yield without reducing DMI (Piantoni et al., 2013), as compared with a no 
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supplemental fat control. Feeding C16:0 at 1 to 4% of ration DM has resulted in gains of milk 
and milk fat yield ranging from 0.8 – 3.3 kg/d and 0.08 – 0.40 kg/d, respectively (Mosley et al., 
2007; Wang et al., 2010; Piantoni et al., 2013; Rico et al., 2014b). Some inconsistencies in milk 
production and DMI responses to C16:0 have been observed, but are likely due to differences in 
study design including C16:0 feeding level, stage of lactation, and length of treatment. 
Supplementing C16:0 clearly increases the energy density of diets fed to cows; however, 
favorable lactation outcomes may not completely depend on the energy content of the 
supplemental C16:0. For instance, C16:0 feeding increases ECM and 3.5% FCM when compared 
with C18:0 supplementation (Rico et al., 2014b).  
Supplementing mid-lactation cows with C16:0 can influence metabolic health status, 
albeit moderately (Pires et al., 2007; Piantoni et al., 2013; Rico et al., 2014b). An increase in 
circulating NEFA with C16:0 supplementation is a consistent observation, relative to C18:0 
(Rico et al., 2014b) or without supplemental fat (Piantoni et al., 2013). Also, an elevation in 
plasma insulin coincides with an increase in C16:0 availability both at the basal level and during 
a glucose challenge (Pires et al., 2007; Piantoni et al., 2013). To our knowledge, the effects of 
high purity C16:0 feeding on insulin sensitivity measurements in mid-lactation cows are limited 
to a single study (Piantoni et al., 2013). Although Piantoni et al. (2013) did not document any 
changes in glucose or insulin tolerance in mid-lactation cows supplemented with C16:0 at 2% of 
diet DM for 21 d, the effects of C16:0 provided at a greater dietary level for an extended duration 
on estimated insulin sensitivity, glucose tolerance, and glucose-stimulated NEFA disappearance 
have not been characterized. In monogastric animals, SFA antagonize insulin action in adipose 
and skeletal muscle tissues by inhibiting insulin-stimulated protein kinase B activation 
(Summers, 2006; Zachut et al., 2013), a response that is accompanied by the accrual of ceramide 
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(Summers, 2006). Interestingly, insulin resistant early lactation cows experience an elevation in 
circulating C16:0 and ceramide (Contreras et al., 2010; Rico et al., 2015). Because the 
availability of lipolysis-derived C16:0 declines with the progression of lactation, an increase in 
C16:0 availability in circulation and tissues may be a means of restoring homeorhetic nutrient 
partitioning to increase milk production. The magnitude of glucose intolerance may depend on 
C16:0 availability; therefore, our objective was to continuously characterize the effects of 
extended C16:0 supplementation on milk production outcomes, metabolic status, and response to 
a glucose challenge in mid-lactation dairy cows. We hypothesized that supplementing C16:0 at a 
high dietary level for a prolonged duration would increase milk and milk fat yield, and decrease 
insulin sensitivity.  
 Materials and methods 
Experimental design 
Dairy cows experience an elevated demand for circulating glucose at the onset of lactation due to 
an increased requirement by the mammary gland for lactose synthesis (Bell, 1995). As a means 
to partition glucose towards the mammary gland, early lactation cows will develop insulin 
resistance to decrease glucose uptake by skeletal muscle and adipose tissues (Bell and Bauman, 
1997; De Koster and Opsomer, 2013). Concomitantly, adipose tissue lipolysis will provide 
NEFA for β-oxidation in peripheral tissues and re-esterification in the mammary gland 
(McNamara and Hillers, 1986; Zachut et al., 2013). Because insulin is an anti-lipolytic hormone, 
insulin resistance can further facilitate the mobilization of NEFA from adipose tissue. These 
homeorhetic adaptations are characteristic metabolic shifts in energy metabolism unique to early 
lactation cows coping with energy insufficiency and experiencing rapid increases in milk 
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production. As lactation progresses beyond peak daily milk yield, insulin-stimulated glucose 
uptake by peripheral tissues increases and circulating NEFA availability declines to minimal 
levels (McNamara and Hillers, 1986; Bell and Bauman, 1997). Furthermore, the restoration of 
positive energy balance is accompanied by the beginning of milk production decline. 
The supplementation of SFA is a nutritional management practice utilized by producers 
to increase the energy density of diets offered to cows during lactation. Feeding cows palmitic 
acid (C16:0) has been reported to improve feed efficiency (Rico et al., 2014a), and increase milk 
yield and milk fat yield without reducing DMI (Piantoni et al., 2013), as compared with a no 
supplemental fat control. Feeding C16:0 at 1 to 4% of ration DM has resulted in gains of milk 
and milk fat yield ranging from 0.8 – 3.3 kg/d and 0.08 – 0.40 kg/d, respectively (Mosley et al., 
2007; Wang et al., 2010; Piantoni et al., 2013; Rico et al., 2014b). Some inconsistencies in milk 
production and DMI responses to C16:0 have been observed, but are likely due to differences in 
study design including C16:0 feeding level, stage of lactation, and length of treatment. 
Supplementing C16:0 clearly increases the energy density of diets fed to cows; however, 
favorable lactation outcomes may not completely depend on the energy content of the 
supplemental C16:0. For instance, C16:0 feeding increases ECM and 3.5% FCM when compared 
with C18:0 supplementation (Rico et al., 2014b).  
Supplementing mid-lactation cows with C16:0 can influence metabolic health status, 
albeit moderately (Pires et al., 2007; Piantoni et al., 2013; Rico et al., 2014b). An increase in 
circulating NEFA with C16:0 supplementation is a consistent observation, relative to C18:0 
(Rico et al., 2014b) or without supplemental fat (Piantoni et al., 2013). Also, an elevation in 
plasma insulin coincides with an increase in C16:0 availability both at the basal level and during 
a glucose challenge (Pires et al., 2007; Piantoni et al., 2013). To our knowledge, the effects of 
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high purity C16:0 feeding on insulin sensitivity measurements in mid-lactation cows are limited 
to a single study (Piantoni et al., 2013). Although Piantoni et al. (2013) did not document any 
changes in glucose or insulin tolerance in mid-lactation cows supplemented with C16:0 at 2% of 
diet DM for 21 d, the effects of C16:0 provided at a greater dietary level for an extended duration 
on estimated insulin sensitivity, glucose tolerance, and glucose-stimulated NEFA disappearance 
have not been characterized. In monogastric animals, SFA antagonize insulin action in adipose 
and skeletal muscle tissues by inhibiting insulin-stimulated protein kinase B activation 
(Summers, 2006; Zachut et al., 2013), a response that is accompanied by the accrual of ceramide 
(Summers, 2006). Interestingly, insulin resistant early lactation cows experience an elevation in 
circulating C16:0 and ceramide (Contreras et al., 2010; Rico et al., 2015). Because the 
availability of lipolysis-derived C16:0 declines with the progression of lactation, an increase in 
C16:0 availability in circulation and tissues may be a means of restoring homeorhetic nutrient 
partitioning to increase milk production. The magnitude of glucose intolerance may depend on 
C16:0 availability; therefore, our objective was to continuously characterize the effects of 
extended C16:0 supplementation on milk production outcomes, metabolic status, and response to 
a glucose challenge in mid-lactation dairy cows. We hypothesized that supplementing C16:0 at a 
high dietary level for a prolonged duration would increase milk and milk fat yield, and decrease 
insulin sensitivity.  
 Glucose tolerance tests 
Glucose tolerance tests (GTT) were performed on d -1, 24, and 49 relative to the start of 
treatment using previously described methods (Pires et al., 2007; Schoenberg et al., 2012). 
Briefly, a jugular catheter was inserted 24 h prior to the GTT, and patency was maintained by 
flushing with heparinized saline every 12 h. Coinciding with the removal of feed at 0800 h, cows 
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were intravenously infused with 300 mg of glucose (dextrose, 50% wt/vol) per kg of BW. 
Glucose infusion occurred within 8 ± 0.88 min, and was followed by a 10-mL saline flush. Blood 
samples (10 mL) were collected at -10, 0, 10, 20, 30, 40, 60, 90, 120, 150, and 180 min relative 
to initiation of glucose infusion. Blood was processed as described above. Feed was provided 
immediately following the completion of the GTT. 
 Sample analyses 
Individually composited feed ingredients were analyzed for NDF with heat-stable α-
amylase and sodium sulfite (Van Soest et al., 1991), CP (AOAC International, 2000; method 
990.03), and starch (Hall, 2009) by Cumberland Valley Analytical Services Inc. (Cumberland, 
MD).  
Plasma samples were analyzed in duplicate for glucose, NEFA, insulin, TAG, and total 
cholesterol. Plasma concentrations of glucose, NEFA, TAG, and cholesterol were determined by 
enzymatic methods using commercial kits (Autokit Glucose, HR series NEFA-HR, L-Type TAG 
M, and Cholesterol E respectively; Wako Chemicals USA Inc., Richmond, VA). Plasma insulin 
concentrations were determined by ELISA (Mercodia Bovine Insulin ELISA; Mercodia AB, 
Uppsala, Sweden). Spectrophotometric measurements were conducted using a SpectraMax Plus 
384 Microplate Reader (Molecular Devices, Sunnyvale, CA). Intra- and interassay CV were 4.6 
and 2.6%, 3.7 and 3.7%, 2.1 and 2.8%, 3.1 and 6.1%, and 3.0 and 7.0% for glucose, NEFA, 
TAG, total cholesterol, and insulin, respectively.  
Individual milk samples were analyzed for fat, true protein, and lactose concentrations, as 
well as MUN using mid-infrared spectroscopy, and SCC was determined by flow cytometry 
(Dairy One, Hagerstown, MD; AOAC, 1990; method 972.160) within 1 wk of collection. For 
analysis of milk FA composition, four individual milk samples were composited based on milk 
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fat yield to represent the covariate period (d -5 and -4), week 3 (d 20 and 21), and week 7 (d 45 
and 46) of the treatment period, and the completion of the post-treatment period (d 62 and 63, 
relative to the start of treatment). Samples were centrifuged at 17,800 × g for 30 min at 4°C and 
fat cakes were collected. Lipids from the fat cakes were extracted, methylated, and FA 
composition determined by GLC, according to previously described methods (Lock et al., 2013). 
Short chain FA methyl esters were corrected for mass discrepancy using the response factors 
described by (Ulberth and Schrammel, 1995). Individual FA yields (g/d) were calculated using 
milk fat yield and FA concentration to determine yield on a mass basis, using the molecular 
weight of each FA while correcting for glycerol and other milk lipid classes (Piantoni et al., 
2013). 
 Calculations and statistical analysis 
Yields of ECM, 3.5% FCM, and milk components were calculated using milk yield and 
components for each milking, summed for daily total, and averaged for each week of collection. 
Energy intake, energy balance, and feed efficiency were calculated as follows: NEL intake = kg 
of DMI × Mcal per kg of apparent dietary NEL; energy balance = NEL intake – (NEM + NEL), 
and feed efficiency = kg of ECM / kg of DMI. Plasma glucose, NEFA, and insulin concentrations 
were measured, and systemic insulin sensitivity estimated using the revised quantitative insulin 
sensitivity check index (RQUICKI) (Holtenius and Holtenius, 2007), where RQUICKI = 1/[log 
(glucose) + log (insulin) + log (NEFA)], and glucose = basal glucose (mg/dL), insulin = basal 
insulin (µU/mL), and NEFA = basal NEFA (mmol/L), such that lowered RQUICKI values 
indicate a reduction in insulin sensitivity, and higher values indicate elevations in insulin 
sensitivity. The area under the curve (AUC) for glucose and NEFA during GTT was calculated 
using the trapezoidal method as previously described by Pires et al. (2007).  
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All data were analyzed using the MIXED model procedure of SAS (version 9.3; SAS 
Institute Inc., Cary, NC) according to the following model: 
 
Yijk =  + Ci + Pj + Tk(i) + (Pj × Tk) + pMY + (pMy × Tk) + eijk 
 
Where Yijk = dependent variable,  = overall mean, Ci = random effect of cow nested within 
treatment (i = 1 to 20), Pj = fixed effect of sampling week (j = 1 to 4), Tk = fixed effect of 
treatment (k = 1 to 2), Pj × Tk  = interaction between sampling week and treatment, pMy = 
preliminary milk yield used as a covariate, pMy × Tk  = interaction between treatment and 
preliminary milk yield, and eijk = residual error. Interactions were evaluated but removed from 
the statistical model when not significant (P > 0.10). For data that were evaluated continuously, 
effect of sampling week was replaced with the effect of sampling day. Normality of the residuals 
was checked with normal probability and box plots and homogeneity of variances with plots of 
residual versus predicted values. When necessary, data were transformed. Preplanned contrasts 
were used to evaluate the differences between cows at each time point. Significance was 
declared at P < 0.05 and trends at P < 0.10. Studentized residual values >3.0 or <-3.0 were 
considered outliers and removed from the analysis (typically 1 per response variable). All results 
are expressed as least squares means and their standard errors, unless stated otherwise.  
 Results 
The C16:0-enriched fat supplement was included at 3.9% of ration DM, with soyhulls 
substituted in the control treatment (Table 1). Content of DM, NDF, CP, and starch, were 
comparable between treatments. Ether extract and NEL were higher in PALM, relative to control. 
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All cows had similar milk yield, ECM, 3.5% FCM, DMI, energy intake, BW, and BCS during 
the covariate period (Table 2). 
 Production responses 
When analyzed continuously, PALM increased DMI by wk 6 (Figure 1; P < 0.05). 
Additionally, PALM increased milk yield by d 15 (26.6 vs. 32.0 kg/d, P < 0.05; Figure 1), a 
response that was observed repeatedly during the remainder of treatment (e.g., 28.3 vs. 32.1 kg/d 
and 24.4 vs. 29.0 kg/d for d 21 and 49, respectively; P ≤ 0.10). Post-treatment, milk yield 
converged for control and PALM, although intermittently (e.g., d 10 after treatment removal; 
25.7 vs 29.1 kg/d, P = 0.06). Coinciding with the start of treatment, energy intake was greater in 
PALM-fed cows (P ≤ 0.10; Figure 1), and was elevated less frequently post-treatment.  
Milk production and composition were further evaluated by pooling samples and data at 
wk 3 and 7 (Table 3). Similar to the continuous evaluation of milk yield, PALM-fed cows 
produced 14 and 19% more milk during wk 3 and 7, respectively (P ≤ 0.08); however, this 
response was not observed post-treatment. PALM treatment increased milk fat yield by 27 and 
18% (P < 0.01), ECM by 14 and 16% (P < 0.05), and 3.5% FCM by 19 and 18% (P < 0.05) at 
wk 3 and 7, respectively, and these responses remained by wk 2 post-treatment. Supplementing 
PALM increased milk protein yield by 15% in cows fed PALM for a 7 wk duration (P = 0.05), 
an effect that remained during the post-treatment evaluation. The PALM treatment did not 
modify milk fat concentration, MUN, or SCC. Although we detected a tendency for increased 
DMI at wk 7 (P = 0.06), we did observe an increase in energy intake (16% average) in cows 
supplemented with PALM (P < 0.05), results that are comparable to the continuous evaluation of 
DMI and energy intake. Furthermore, feed efficiency tended to be greater for PALM-fed cows 
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after treatment (P = 0.08). We did not observe any differences in BCS, BW, or energy balance 
for PALM versus control treatments.  
 Milk fatty acid yields and concentrations 
Relative to control, PALM increased milk C16:0 yield by 52 and 46% by wk 3 and 7, 
respectively (P < 0.001; Table 4). Similar observations were observed for milk C16:1. In 
contrast, the yield of C16:0 in milk was similar for both groups two weeks following the 
termination of treatments. Although the total yield of preformed FA in milk remained unchanged 
during the treatment period, milk SFA yield increased by 29 and 24% in PALM-fed cows at wk 
3 and 7, respectively (P < 0.001). Total yields of FA synthesized de novo, as well as MUFA and 
PUFA in milk remained unchanged during the treatment period. Interestingly, we observed 24 
and 22% increases in yields of de novo and preformed FA in PALM cows post-treatment (P < 
0.01). For example, post-treatment increases in milk yields of C6:0, C8:0, C10:0, C12:0, C14:0, 
18:0, cis-9 C18:1, and cis-9, cis-12 C18:2 ranged from 18 to 36% (P ≤ 0.05) in PALM versus 
control cows. 
In a similar manner, PALM modified the concentrations of milk FA (Table 5). Relative to 
control, PALM increased milk C16:0 concentration by 26 and 21% at wk 3 and 7, respectively 
(P < 0.001). Likewise, SFA concentration increased by 4.3 and 3.9% in PALM cows at wk 3 and 
7, respectively (P < 0.05). In contrast, the concentrations of unsaturated FA were lower in PALM 
cows. The concentrations of most de novo synthesized FA were 18 and 12% lower in PALM 
cows by wk 3 and 7, respectively (P < 0.01). For example, PALM lowered the concentrations of 
C6:0, C8:0, C10:0, C12:0, and C14:0 FA in milk, which ranged from 10 to 26% at wk 3 (P < 
0.01). In contrast to changes in milk FA yields, we did not detect any treatment differences in the 
concentrations of milk FA, including C16:0, during the post-treatment period.   
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 Plasma metabolite responses 
The PALM treatment increased circulating NEFA by 48, 93, and 60% on d 4, 6, and 8 of 
treatment, respectively (interaction P < 0.05; Figure 2); however, coinciding with enhanced milk 
production, PALM did not affect plasma NEFA following d 8. Consistent with the advancement 
of lactation, the level of NEFA in plasma declined with time in all cows (P < 0.01). 
Unexpectedly, we observed a higher concentration of insulin in control-fed cows at the onset of 
treatment (interaction P < 0.05; Figure 2). We also measured a gradual rise in circulating insulin 
with the progression of lactation (P < 0.05). We did not detect any changes in circulating glucose 
with treatment (Figure 2). In parallel with our observed plasma NEFA response, PALM cows 
displayed lower RQUICKI values at d 6 and 8 (38 and 35%, respectively; P < 0.01; Figure 2), 
reflecting an acute decrease in estimated insulin sensitivity in PALM-fed cows. Although PALM 
increased circulating NEFA during the short-term, PALM did not modify circulating TAG 
(Figure 3). Conversely, total cholesterol concentration in plasma was 50 and 51% greater in 
PALM cows by wk 3 and 7, respectively (P < 0.01; Figure 3). 
 Supplementing cows with PALM did not modify circulating glucose following 
intravenous glucose infusion during the duration of treatment (Figure 4). Furthermore, PALM 
did not modify glucose AUC during the GTT (Table 7). The magnitude of plasma NEFA 
disappearance following a glucose challenge progressively decreased with duration of PALM 
treatment (Figure 4). Such that PALM-fed cows had a tendency for reduced NEFA 
disappearance 60 min after glucose infusion (nadir of curve) on wk 3 of treatment (P < 0.10), a 
response that was significantly greater by wk 7 (interaction P < 0.001). Additionally, PALM 
increased AUC for NEFA during the GTT (Table 7).  
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 Discussion 
Previous research studies that evaluated the effects of C16:0-enriched supplements on 
milk production have included short-term study lengths, varying dietary levels of C16:0, and 
brief sampling windows near the end of treatment (Loften et al., 2014), collective work that have 
had variable production responses. Furthermore, the effects of prolonged C16:0 supplementation 
for 7 wk or the effects following treatment removal on milk production and composition have 
not been investigated. Moreover, the relationship between C16:0 supplementation, insulin 
sensitivity, and nutrient partitioning in mid-lactation cows has been considered in a single study 
(Piantoni et al., 2013). Considering that circulating lipid availability is linked with the 
development of insulin resistance and nutrient partitioning during early lactation, and that 
increasing circulating SFA can antagonize insulin action, we chose to further explore the effects 
of dietary C16:0 on systemic glucose tolerance and lipolytic response following a series of 
glucose challenges. Because beneficial changes in milk production outcomes are inconsistent and 
Piantoni et al. (2013) did not observe a change in glucose tolerance when C16:0 was fed at 2% of 
diet DM for 3 wk, we chose to utilize a high dietary feeding level of C16:0 (3.9% of diet DM) 
relative to industry applications for a longer period of time (7 wk). Our feeding level was 
comparable to previous work by Steele (1969) and Mosley et al. (2007). We also evaluated 
changes in milk production and composition following the 2 wk removal of supplemental C16:0. 
Although we did not record improvements in milk yield with C16:0 until d 13 of PALM 
treatment, daily milk yields averaged 26.3 and 29.7 kg (control vs. PALM, respectively) over the 
duration of the 49-d treatment. Furthermore, maximum gains of 4.8 kg/d were observed in cows 
consuming supplemental C16:0 at 3.9% of diet DM (1,013 g/d) by wk 7. Our observed increases 
in milk yield are comparable to Mosley et al. (2007), who observed 3.3 kg/d of milk produced by 
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cows consuming 1,000 g/d of an C16:0-enriched supplement (808 g/d) for 16 d, when compared 
with a non-supplemented control diet. Likewise, Steele (1969) reported increases in milk yields 
by 1 kg/d in cows supplemented with C16:0 (~85% C16:0) at 4.25% of diet for 35 d, relative to 
no added fat. Comparable to Piantoni et al. (2013), we did not detect a significant change in DMI 
at wk 3; however, our continued gains in milk yield beyond wk 3 were coupled with a trend for 
increased DMI. Because treatment increased ECM at wk 3 and wk 7, and tended to increase DMI 
by wk 7, feed efficiency (kg of ECM / kg of DMI) tended to be higher in PALM-fed cows. In 
contrast to other studies that compared diets supplemented with C16:0 with non-supplemented 
controls (Steele, 1969; Mosley et al., 2007; Piantoni et al., 2013), PALM did not increase milk 
fat, protein, or lactose concentrations. However, PALM supplementation did increase milk fat 
yield (+300 and +200 g/d by wk 3 and 7, respectively). At comparable C16:0 treatment levels, 
Mosley et al. (2007) and Steele (1969) reported gains in milk fat yields of 302 and 115 g/d, 
respectively. Our results also demonstrate that improvements in milk fat yield with PALM 
treatment are sustained for the duration of a 7 wk treatment period. Comparable to others (Steele, 
1969; Mosley et al., 2007; Piantoni et al., 2013), we did not observe changes in milk protein 
yield by wk 3; however, milk protein yield was greater in PALM fed cows by wk 7 (+130 g/d). 
Because we observed an increase in energy intake due to increased dietary C16:0, AA utilization 
may have been partitioned away from non-mammary tissues and towards milk protein synthesis. 
Similar to others (Piantoni et al., 2013; Rico et al., 2014b), we observed an increase in ECM and 
3.5% FCM by wk 3 (14 and 19%, respectively). Because BCS and BW were not significantly 
different between treatments, we consider that increased energy intake may have been diverted 
towards milk and milk component production and away from adipose or skeletal muscle tissue 
accretion. Two weeks following the removal of PALM, milk yield started to converge between 
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the treatment groups; however, ECM and 3.5% FCM remained elevated in parallel with a 
sustained elevation in milk fat and protein yields. The post-treatment increase in ECM and 3.5% 
FCM occurred in parallel with a continued increase in energy intake observed in cows previously 
fed PALM. 
Our observed changes in milk FA yields during PALM are consistent with related studies 
(Mosley et al., 2007; Lock et al., 2013; Piantoni et al., 2013). Treatment with C16:0 did not 
affect de novo synthesized or preformed FA yields in milk during treatment; however, PALM 
did increase SFA yields due to an increase in C16:0 incorporation. The absence of an increase in 
de novo FA synthesis with enhanced milk yield may be due to the allosteric inhibition of acetyl-
CoA carboxylase (Storry et al., 1973; Wright et al., 2002). As opposed to treatment, the removal 
of supplemental C16:0 for 2 wk increased de novo milk fat synthesis. Additionally, the removal 
of supplemental C16:0 enhanced the incorporation of preformed FA into milk fat. The observed 
increase in de novo and preformed FA in milk post-treatment may reflect the sustained elevation 
in energy intake, albeit elevated dietary energy was independent of C16:0. The cow’s ability to 
remodel milk FA composition to maintain elevated ECM and milk fat yield for two weeks 
beyond C16:0 removal is intriguing, and the extent of this preservation should be further 
investigated.   
Saturated FA feeding has been reported to increase circulating NEFA in dairy cows 
(Piantoni et al., 2013; Rico et al., 2014b). In our study, the basal concentrations of NEFA in 
plasma were elevated in PALM-fed cows exclusively during the initial two weeks of treatment, 
immediately prior to enhanced daily yields of milk and milk fat. The ability of supplemental SFA 
to increase NEFA is well documented (Grummer, 1991). For instance, Rico et al. (2014b) 
observed elevated plasma NEFA in mid-lactation cows fed C16:0, relative to C18:0 feeding 
  
45 
 
(Rico et al., 2014b). The mechanisms responsible for these elevations in NEFA observed with 
C16:0 feeding have not been delineated. The rise in circulating NEFA may be caused by the 
enhanced intake of dietary C16:0; however, we recognize that FA greater than C12 are converted 
to their CoA derivatives and re-esterified as TAG once absorbed (Bach and Babayan, 1982). The 
TAG are subsequently packaged into chylomicrons and readily hydrolyzed by lipoprotein lipase 
in tissues (Christie et al., 1986). Therefore, the elevations in NEFA observed with PALM may be 
from dietary origin. Alternatively, an increase in circulating NEFA may reflect greater adipose 
tissue lipolysis in cows fed C16:0, as suggested by Piantoni et al. (2013); however, we did not 
observe a change in BCS in PALM-fed cows experiencing positive energy balance. Although not 
evaluated by Piantoni et al. (2013), we observed an acute decrease in plasma insulin 
concentrations within the first week of C16:0 feeding; therefore, the anti-lipolytic action of 
insulin may have been diminished to support short-term NEFA mobilization. In support, we 
observed a gradual increase in circulating insulin concurrent with a decline in plasma NEFA as 
cows progressed towards late lactation. Similar to Piantoni et al. (2013), we did not observe a 
change in plasma TAG in cows fed C16:0; however, we did observe a 51% increase in 
circulating total cholesterol by wk 7. The abomasal infusion of FA of palm oil or the feeding of 
C16:0-incorporated diets has also been shown to increase the concentration of cholesterol in 
plasma (Bremmer et al., 1998; van Knegsel et al., 2007; Andersen et al., 2008). Our observed 
rise in circulating cholesterol with PALM may be due to enhanced formation and lower turnover 
of low-density lipoproteins, as suggested by Fernandez and West (2005). 
The ability of SFA to antagonize insulin action and promote glucose intolerance is well 
documented in monogastrics (Summers, 2006; Funaki, 2009) however, the ability of SFA to 
modify insulin action in ruminants is uncertain. In our evaluation of 7-wk C16:0 
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supplementation, we did not observe a change in estimated insulin sensitivity or systemic 
glucose tolerance in PALM-fed cows at wk 3 or 7. Comparably, Piantoni et al. (2013) did not 
observe a change in systemic insulin sensitivity in mid-lactation cows fed C16:0 at 2% of diet 
DM following 3 wk of supplementation, as measured using a GTT as well as an insulin tolerance 
test. Induction of hyperlipidemia by abomasally infusing tallow or restricting access to feed 
impairs glucose clearance during a GTT in non-lactating, non-pregnant Holstein cows (Pires et 
al., 2007); however, augmented NEFA availability during early lactation does not diminish 
glucose clearance (Saed Samii et al., 2015; Mann et al., 2016). In lactating cows, the inability of 
SFA to suppress glucose removal following a challenge is likely due to enhanced glucose uptake 
by the mammary gland (Kronfeld, 1982; Debras et al., 1989), a possible explanation for the 
similar glucose tolerance measurements observed in our study. Prior to the increase in milk yield, 
we did observe a decrease in estimated insulin sensitivity exclusively at wk 1 of 
supplementation, a response that disappeared as the availability of basal plasma insulin increased 
and plasma NEFA declined with the progression of lactation. The evaluation of RQUICKI across 
time (i.e. stages of lactation) should be evaluated carefully because this indice of insulin 
sensitivity does not correspond to direct measurements of insulin sensitivity (GTT or insulin 
tolerance testing; Saed Samii et al., 2015; Mann et al., 2016), and does not account for NEFA 
that may be derived from dietary origin. Because the development of FA-induced insulin 
resistance in lactating dairy cows may be localized to adipose tissue (Zachut et al., 2013), we 
evaluated changes in circulating NEFA during a series of GTT measurements and observed a 
progressive decline in glucose-stimulated NEFA disappearance in PALM-fed cows. Because 
insulin can suppress adipose tissue lipolysis, C16:0-induced adipose tissue insulin resistance may 
have lessened the anti-lipolytic effect of the glucose challenges. The ability of C16:0 to 
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antagonize protein kinase B-dependent insulin signaling in adipose tissue may be mediated by 
lipid mediators such as ceramide, biomarkers for insulin resistance in insulin resistant humans 
(Haus et al., 2009) and dairy cattle (Rico et al., 2015). The possible role of C16:0 to mediate 
adipose tissue insulin resistance and support glucose partitioning to the mammary gland requires 
further consideration. 
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Conclusion 
Optimizing milk yield and components through supplementation of SFA is a current 
interest of many producers and researchers. Although milk fat and in most cases milk yield are 
known to increase with C16:0 supplementation to lactating cows, the mechanism through which 
this occurs remains elusive. Therefore, our objective was to evaluate changes in metabolism 
associated with production responses to long-term feeding of C16:0 to mid-lactation dairy cows. 
Our results demonstrate that long-term feeding of mid-lactation cows with C16:0 enhances the 
yield of milk and milk components for a 7 wk duration without suppressing DMI, relative to no 
added fat supplementation. Gains in milk fat yield during C16:0 supplementation were 
exclusively due to an increase in C16:0 and C16:1 incorporation into milk fat. The evaluation of 
metabolic health status revealed acute elevations in circulating NEFA and estimated insulin 
resistance that preceded beneficial improvements in milk production. Although glucose tolerance 
was not modified with C16:0 feeding, the intake of C16:0 for an extended duration enhanced 
circulating cholesterol and lowered glucose-stimulated NEFA disappearance. Intriguingly, 
beneficial milk production responses were sustained for two weeks following the removal of 
C16:0 from the diet. Further studies are required to investigate the effects of C16:0 on localized 
adipose tissue insulin sensitivity and nutrient partitioning towards the mammary gland.   
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TABLES AND FIGURES 
 
Table 1. Ingredients and nutrient composition (% of DM unless otherwise noted) of experimental 
diets supplemented with palmitic acid (PALM; C16:0) and control (no added fat). 
 
Treatment 
Item Control PALM 
Ingredient (% DM) 
      Sorghum sudagrass 30.3 30.1 
    Ground corn 29.1 28.9 
    Alfalfa haylage 15.7 15.5 
    Soybean meal 11.4 11.3 
    Soyhulls 6.60 3.60 
    Beet pulp pellets 2.90 2.80 
    Vitamin and mineral premix
1 
0.63 0.60 
    Protein blend
2 
1.60 1.60 
    Sodium bicarbonate 0.97 0.94 
    Zeolite 0.48 0.47 
    Limestone 0.32 0.29 
    C16:0-enriched fat supplement
3 
0.00 3.90 
Nutrient composition   
    DM, % 59.6 59.8 
    CP, % DM 17.8 17.3 
    NDF, % DM 33.6 31.6 
    Forage NDF, % DM 24.8 24.8 
    Starch, % DM 21.7 21.6 
    Ether extract, % DM 2.80 6.70 
    Ash, % DM 12.6 13.1 
    NEL, Mcal/kg DM 1.40 1.50 
1
Vitamin-mineral mix contained 14% Ca, 9.5% P, 6.3% Mg, 0.13% K, 0.78% S, 4%Na, 17.6% 
C, 4282 ppm Fe, 3000 ppm Zn, 590 ppm Cu, 1600 ppm Mn, 62 ppm Se, 53 ppm Co, and 31 ppm 
I, as well as 507 KIU Vit. A, 69 KIU Vit. D, and 1997.6 KIU Vit. E. 
2
Protein blend contained 30.1% canola meal solvent, 1.05% smartamine (Adisseo, Antony, 
France), 11.1% corn gluten meal (60%), 45.7% soy plus, and 12.1% blood meal. 
3
Palmitic acid supplement contained 98% C16:0 (Palmit 98; Global Agri-Trade, Long Beach, 
CA, USA).  
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Table 2. Production variables during covariate period. 
 Treatment
1 
  
                   Item Control PALM SEM P-value 
Milk Yield, kg/d 24.5 26.5 1.50 0.39 
     
Milk solids, kg/d     
Fat 1.00 1.09 0.05 0.22 
Protein 0.71 0.74 0.04 0.60  
Lactose 1.12 0.95 0.12 0.32 
     
Milk composition, %     
Fat 4.06 4.15 0.19 0.75 
Protein 2.90 2.81 0.11 0.52 
Lactose 4.83 5.07 0.08 0.04 
     
SCC × 1000/mL 28.9 24.9 7.50 0.70 
     
MUN, mg/dL 17.9 16.5 0.91 0.21 
     
ECM 20.5 23.7 1.90 0.27 
     
3.5% FCM 26.9 29.3 1.50 0.25 
  
 
  
DMI, kg/d 27.8 26.4 1.30 0.44 
     
NEL intake, Mcal/d
2 
40.6 39.3 1.50 0.53 
     
Feed efficiency
3
 0.82 0.88 0.08 0.59 
     
BCS 2.51 2.69 0.09 0.16 
 
    
BW, kg
 
619 663 18.0 0.09 
 
    
Energy balance, Mcal/d
4
 20.5 10.5 2.50 <0.01 
Values are presented as LS Means ± SEM. *, P < 0.05.  
1
Treatments were either PALM (palmitic acid at 3.9% of diet DM) or control (no added fat).  
2
NEL intake (Mcal/d) = DMI (kg) × dietary NEL (Mcal/kg). 
3
Feed efficiency = ECM (kg) / DMI (kg). 
4
Energy balance = NEL intake – (NEM + NEL). 
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Table 3. Production responses to palmitic acid supplementation. 
 Treatment1     P-value 
 Week 3 Week 7 Post-treatment Main Effects2 
                     Item Control PALM SEM Control PALM SEM Control PALM SEM Treatment Time 
Treatment × Time 
Milk Yield, kg/d 27.7 31.6* 1.50 25.7 30.5* 1.60 25.4 28.5 1.60   0.07 <0.01  0.58 
             
Milk solids, kg/d             
Fat 1.14 1.40** 0.05 1.10 1.33** 0.06 1.00 1.20* 0.06 <0.01 <0.01  0.46 
Protein 0.94 0.98 0.04 0.87 1.00* 0.04 0.87 1.0* 0.04   0.05 <0.01  0.33 
Lactose 1.37 1.57† 0.09 1.34 1.51 0.09 1.27 1.43 0.09   0.40   0.01  0.22 
             
Milk composition, %             
Fat 4.12 4.39 0.19 4.26 4.33 0.20 4.07 3.88 0.19 0.83 <0.01 0.14 
Protein 3.24 3.13 0.14 3.44 3.30 0.14 3.52 3.40 0.14 0.65 <0.01 0.24 
Lactose 4.95 4.96 0.06 4.99 4.97 0.06 4.99 5.00 0.06 0.50 0.67 0.09 
             
SCC × 1000/mL 60.4 39.6 13.7 100 60.2 22.5 96.7 58.9 21.8 0.23 <0.01 0.23 
             
MUN, mg/dL 15.4 14.2 0.76 14.4 14.2 0.77 18.5 17.6 0.77 0.30 <0.01 0.70 
             
ECM 29.1 33.3* 1.40 27.8 32.3* 1.50 25.5 31.3** 1.50 <0.01 <0.01 0.83 
             
3.5% FCM 30.5 36.3** 1.40 29.4 34.7* 1.50 27.4 33.6** 1.50 <0.01 <0.01  0.42 
             
DMI, kg/d 25.6 28.1 1.30 23.1 26.5† 1.30 26.3 28.0 1.30   0.15 0.18  0.23 
             
NEL intake,
 Mcal/d3 35.8 42.2** 1.40 33.9 39.8** 1.50 37.1 42.0* 1.50 <0.01 0.19 0.04 
             
Feed efficiency4  1.10 1.18 0.06 1.12 1.21 0.06 0.98 1.13† 0.06 0.08 <0.01 0.92 
             
BCS 2.60 2.74 0.09 2.78 2.87 0.09 2.75 2.85 0.09 0.32 <0.01 0.36 
             
BW, kg 642 679 18.0 658 691 18.2 666 705 18.3 0.12 <0.01 0.88 
             
Energy balance, Mcal/d5 4.56 6.87 1.30 3.64 5.10 1.50 7.43 7.88 1.30 0.21 <0.01 0.01 
Values are presented as LS Means ± SEM for each sampling period. 
Significance within wk 3, wk 7, and post-treatment P-values:  *, P < 0.05; **, P < 0.01; †, P < 0.10.  
1
Treatments were either PALM (palmitic acid at 3.9% of diet DM) or control (no added fat).  
2
Main effects across all time points. 
3
NEL intake (Mcal/d) = DMI (kg) × dietary NEL (Mcal/kg). 
4
Feed efficiency = ECM (kg) / DMI (kg). 
5
Energy balance = NEL intake – (NEM + NEL). 
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Table 4. Milk fatty acid yields (g/d) of cows fed treatment diets. 
 Treatment1    P-value 
 Week 3 Week 7 Post-treatment Main Effects
2 
 Control PALM SEM Control PALM SEM Control PALM SEM Treatment Time 
Treatment × 
Time 
Selected individual FA             
     4:0 29.1 34.5* 1.60 28.9 33.9* 1.70 26.5 30.4 1.60 0.01 0.02 0.57 
     6:0 22.1 23.2 1.10 20.8 22.7 1.10 19.6 23.4* 1.10 0.04 0.01 0.04 
     8:0 13.9 13.4 0.70 13.0 13.1 0.76 12.5 15.3** 0.76 0.16 <0.01 0.16 
     10:0 37.9 34.9 2.40 35.1 34.2 2.50 34.8 46.5** 2.50 0.24 <0.01 0.24 
     12:0 47.3 42.1 3.40 43.9 41.7 3.50 43.7 59.3** 3.40 0.41 <0.01 0.41 
     13:0 2.32 2.02 0.16 2.29 2.11 0.16 2.16 2.75* 0.17 0.66 <0.01 0.66 
     14:0 134 128 7.10 125 125 7.30 118 146** 7.30 0.20 <0.01 0.20 
     14:1 cis-9 11.1 11.5 0.87 11.5 11.8 0.89 9.8 12.1 0.91 0.41 <0.01 0.41 
     15:0 10.4 9.8 0.69 10.6 10.4 0.72 10.3 13.6** 0.72 0.31 <0.01 0.31 
     16:0 412 627*** 26.0 416 607*** 27.5 352 403 27.3 <0.01 <0.01 <0.01 
     16:1 cis-9 23.5 30.1** 1.80 22.8 30.1** 1.90 18.9 20.8 1.80 0.08 <0.01 0.08 
     17:0 6.27 5.57 0.33 6.34 5.81 0.35 5.88 7.57*** 0.35 0.39 0.02 0.39 
     18:0 66.5 70.3 5.80 63.7 58.5 6.10 63.3 82.6* 6.01 0.22 <0.01 0.22 
     18:1 trans-4 0.08 0.07* 0.01 0.05 0.05 0.01 0.07 0.08* 0.01 0.56 <0.01 0.56 
     18:1 trans-6-8 1.42 1.46 0.08 1.25 1.27 0.09 1.27 1.66*** 0.08 0.04 0.01 0.04 
     18:1 trans-9 1.25 1.12 0.05 1.05 0.99 0.05 1.05 1.30*** 0.05 0.21 0.01 0.21 
     18:1 trans-10 2.05 1.97 0.09 1.49 1.49 0.10 1.74 1.99 0.10 0.34 <0.01 0.34 
     18:1 trans-11 5.08 4.13 0.35 6.26 5.26 0.37 5.79 7.38*** 0.36 0.48 <0.01 0.48 
     18:1 trans-12 1.72 1.46** 0.09 1.31 1.10 0.10 1.46 1.88*** 0.09 0.74 <0.01 0.74 
     18:1 cis-9 181 190 7.15 158 167 7.80 151 178** 7.40 0.03 <0.01 0.03 
     18:1 cis-11 4.81 4.64 0.21 3.95 4.08 0.22 3.81 4.57** 0.22 0.11 <0.01 0.11 
     18:1 cis-12 1.84 1.69 0.09 1.47 1.47 0.09 1.50 2.04*** 0.09 0.12 <0.01 0.12 
     18:1 cis-13 0.50 0.36* 0.05 0.32 0.25 0.05 0.27 0.39 0.05 0.97 <0.01 0.97 
     18:1 cis-14, trans-16 1.45 1.35 0.08 1.18 1.31 0.09 1.29 1.63*** 0.08 0.22 <0.01 0.22 
     18:2 cis-9, cis-12 22.8 24.1 1.10 19.2 21.1 1.20 19.4 26.0*** 1.20 <0.01 <0.01 <0.01 
     18:3 cis-9, cis-12, cis-15 2.94 2.87 0.18 3.55 3.72 0.18 3.54 4.67** 0.19 0.03 <0.01 0.03 
     CLA cis-9, trans-11 3.23 2.48** 0.21 3.74 3.28 0.22 3.42 3.92 0.2 0.74 <0.01 0.74 
Summations3             
     De novo 279 288 17.2 278 281 18.1 265 328** 18.0 0.16 <0.01 0.16 
     Both 435 657*** 26.8 439 637*** 28.3 370 423 28.2 <0.01 <0.01 <0.01 
     Preformed   351 361 15.0 321 323 15.9 309 376** 15.8 0.01 0.03 0.01 
      Σ SFA 766 991*** 44.7 766 953*** 47.2 690 821* 47.0 <0.01 <0.01 <0.01 
      Σ MUFA-cis 224 239 9.50 199 216 10.1 186 219* 10.1 0.01 <0.01 0.01 
      Σ PUFA-cis  25.7 27.0 1.30 22.8 24.8 1.40 22.9 30.6*** 1.40 <0.01 <0.01 <0.01 
      Σ Unknown 26.4 27.3 1.10 24.2 24.6 1.10 22.9 28.8*** 1.10 0.01 0.17 0.01 
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Values are presented as LS Means ± SEM.  
Significance within wk 3, wk 7, and post-treatment P-values:  *, P < 0.05; **, P < 0.01; †, P < 0.10. 
1
Treatments were either PALM (C16:0 at 3.9% of diet DM) or control (no added fat).  
2
Main effects across all time points. 
3
De novo FA originate from mammary de novo synthesis (<16 carbons), performed FA from extraction from plasma (>16 carbons), 
and both FA originate from both sources (C16:0 plus cis-9 C16:1).  
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Table 5. Milk fatty acid concentration (g/100g) of cows fed treatment diets. 
 Treatment1    P-value 
 Week 3 Week 7 Post-treatment Main Effects
2
 
 
Control PALM SEM Control PALM SEM Control PALM SEM Treatment Time 
Treatment × 
Time 
Selected individual FA             
     4:0 2.73 2.64 0.07 2.79 2.66 0.07 2.78 2.67 0.07 0.24 <0.01 0.96 
     6:0 1.99 1.77*** 0.04 1.97 1.83* 0.04 2.06 2.05 0.04 0.07 <0.01 <0.01 
     8:0 1.25 1.02*** 0.03 1.21 1.06*** 0.03 1.32 1.33 0.03 0.02 <0.01 <0.01 
     10:0 3.41 2.65*** 0.13 3.27 2.75*** 0.13 3.66 3.83 0.13 0.09 <0.01 <0.01 
     12:0 4.24 3.19*** 0.20 4.06 3.36* 0.20 4.57 4.88 0.20 0.17 <0.01 <0.01 
     13:0 0.19 0.15* 0.01 0.18 0.16 0.01 0.22 0.24 0.01 0.55 <0.01 0.01 
     14:0 12.0 9.8*** 0.31 11.4 10.1*** 0.31 12.3 12.8 0.31 0.05 <0.01 <0.01 
     14:1 cis-9 1.02 0.89 0.07 0.90 0.94 0.07 1.01 1.08 0.07 0.83 <0.01 0.10 
     15:0 0.95 0.76*** 0.04 0.96 0.83 0.04 1.09 1.21 0.04 0.34 <0.01 <0.01 
     16:0 38.2 48.0*** 1.1 40.2 48.8*** 1.0 36.8 35.8 1.0 <0.01 <0.01 <0.01 
     16:1 cis-9 2.22 2.35 0.16 2.05 2.44 0.16 1.98 1.90 0.16 0.76 <0.01 0.01 
     17:0 0.58 0.42*** 0.01 0.60 0.46*** 0.01 0.62 0.66 0.01 <0.01 <0.01 <0.01 
     18:0 6.33 5.28 0.43 6.29 4.68** 0.43 6.75 6.77 0.43 0.44 <0.01 <0.01 
     18:1 trans-4 0.01 0.01** <0.01 <0.01 <0.01*** <0.01 <0.01 0.01 <0.01 0.05 <0.01 0.02 
     18:1 trans-6-8 0.13 0.11*** <0.01 0.12 0.10* <0.01 0.13 0.13 <0.01 0.27 <0.01 <0.01 
     18:1 trans-9 0.12 0.08*** <0.01 0.10 0.08*** <0.01 0.11 0.11 <0.01 <0.01 <0.01 <0.01 
     18:1 trans-10 0.19 0.15*** <0.01 0.14 0.11* <0.01 0.18 0.17 <0.01 0.10 <0.01 <0.01 
     18:1 trans-11 0.48 0.31*** 0.02 0.62 0.42*** 0.02 0.61 0.61 0.02 0.01 <0.01 <0.01 
     18:1 trans-12 0.16 0.10*** <0.01 0.12 0.09*** <0.01 0.15 0.15 <0.01 0.02 <0.01 <0.01 
     18:1 cis-9 16.2 14.6 0.66 15.7 13.5* 0.66 16.2 16.0 0.66 0.46 <0.01 <0.01 
     18:1 cis-11 0.43 0.35*** 0.02 0.38 0.33 0.02 0.40 0.40 0.02 0.16 <0.01 0.01 
     18:1 cis-12 0.18 0.12*** <0.01 0.14 0.11** <0.01 0.15 0.18 <0.01 0.20 <0.01 <0.01 
     18:1 cis-13 0.05 0.02*** <0.01 0.03 0.02 <0.01 0.03 0.03 <0.01 0.19 <0.01 <0.01 
     18:1 cis-14, trans-16 0.13 0.10*** <0.01 0.11 0.09** <0.01 0.13 0.13 <0.01 0.10 <0.01 <0.01 
     18:2 cis-9, cis-12 2.18 1.84*** 0.09 1.88 1.71 0.09 2.09 2.29 0.09 0.74 <0.01 <0.01 
     18:3 cis-9, cis-12, cis-15 0.28 0.21*** 0.01 0.34 0.29* 0.01 0.37 0.41 0.01 0.21 <0.01 <0.01 
     CLA cis-9, trans-11 0.29 0.19*** 0.01 0.33 0.26* 0.01 0.35 0.34 0.01 0.07 <0.01 <0.01 
Summations3             
     De novo 26.6 21.9*** 0.65 25.6 22.5*** 0.65 27.8 28.7 0.65 0.03 <0.01 <0.01 
     Both 40.4 50.3*** 1.10 42.2 51.2*** 1.00 38.8 37.7 1.10 <0.01 <0.01 <0.01 
     Preformed   32.2 27.6*** 1.00 30.6 26.1*** 1.00 33.0 33.4 1.00 0.11 <0.01 <0.01 
      Σ SFA 72.6 75.7* 0.91 73.7 76.6* 0.91 72.5 72.4 0.91 0.35 <0.01 <0.01 
      Σ MUFA-cis 20.2 18.4 0.75 19.3 17.5 0.75 20.0 19.7 0.75 0.54 <0.01 <0.01 
      Σ PUFA-cis  2.46 2.06*** 0.10 2.22 2.01 0.10 2.47 2.70 0.10 0.66 <0.01 <0.01 
      Σ Unknown 2.51 2.09*** 0.08 2.27 1.99** 0.08 2.47 2.57 0.08 0.07 <0.01 <0.01 
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Values are presented as LS Means ± SEM. *, P < 0.05; **, P < 0.01; ***, P < 0.001. 
Significance within wk 3, wk 7, and post-treatment P-values:  *, P < 0.05; **, P < 0.01; †, P < 0.10. 
1
Treatments were either PALM (C16:0 at 3.9% of diet DM) or control (no added fat).  
2
Main effects across all time points. 
3
De novo FA originate from mammary de novo synthesis (<16 carbons), performed FA from extraction from plasma (>16 carbons), 
and both FA originate from both sources (C16:0 plus cis-9 C16:1).  
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Table 6. Milk fatty acid yield (g/d) and concentration (g/100g) during covariate period. 
 Yield  Concentration  
Treatment
1
: Control PALM SEM P-value Control PALM SEM P-value 
Selected individual FA         
     4:0 27.2 28.8 1.60 0.48 2.89 2.79 0.07 0.37 
     6:0 18.6 20.1 1.10 0.34 1.96 1.94 0.04 0.78 
     8:0 10.8 11.9 0.72 0.27 1.13 1.15 0.03 0.74 
     10:0 27.2 30.3 2.40 0.35 2.83 2.92 0.13 0.64 
     12:0 32.0 35.5 3.40 0.46 3.34 3.41 0.20 0.80 
     13:0 1.31 1.54 0.16 0.34 0.15 0.14 0.01 0.77 
     14:0 99.6 111 6.90 0.23 10.5 10.7 0.31 0.55 
     14:1 cis-9 8.39 8.80 0.87 0.74 0.89 0.84 0.07 0.61 
     15:0 8.62 9.23 0.69 0.53 0.90 0.89 0.04 0.81 
     16:0 359 371 26.0 0.74 37.9 35.9 1.10 0.19 
     16:1 cis-9 20.2 20.5 1.80 0.91 2.15 1.97 0.16 0.44 
     17:0 5.50 6.18 0.33 0.15 0.58 0.59 0.01 0.56 
     18:0 72.8 84.7 5.80 0.15 7.29 8.29 0.43 0.11 
     18:1 trans-4 0.05 0.06 0.01 0.15 0.01 0.01 <0.01 0.54 
     18:1 trans-6-8 1.16 1.35 0.08 0.11 0.12 0.13 <0.01 0.37 
     18:1 trans-9 1.04 1.20 0.05 0.04 0.11 0.12 <0.01 0.46 
     18:1 trans-10 1.54 1.74 0.10 0.18 0.17 0.18 <0.01 0.36 
     18:1 trans-11 4.57 5.71 0.35 0.02 0.49 0.55 0.02 0.10 
     18:1 trans-12 1.37 1.61 0.09 0.08 0.15 0.16 <0.01 0.40 
     18:1 cis-9 174 194 7.30 0.06 18.0 19.9 0.69 0.05 
     18:1 cis-11 4.53 5.02 0.21 0.11 0.47 0.50 0.02 0.24 
     18:1 cis-12 1.48 1.69 0.09 0.11 0.16 0.18 <0.01 0.22 
     18:1 cis-13 0.51 0.62 0.05 0.13 0.05 0.06 <0.01 0.17 
     18:1 cis-14, trans-16 1.20 1.41 0.08 0.09 0.13 0.14 <0.01 0.33 
     18:2 cis-9, cis-12 17.8 21.7 1.20 0.02 1.91 2.11 0.09 0.11 
     18:3 cis-9, cis-12, cis-15 2.63 3.01 0.18 0.14 0.29 0.29 0.01 0.67 
     CLA cis-9, trans-11 2.64 3.04 0.21 0.19 0.29 0.29 0.02 0.80 
Summations
2 
        
     De novo 223 247 17.2 0.34 23.5 23.8 0.65 0.76 
     Both 380 392 26.8 0.74 40.1 37.9 1.10 0.16 
     Preformed   337 391 15.0 0.01 36.3 38.2 1.00 0.21 
      Σ SFA 663 712 44.7 0.44 71.2 68.9 0.91 0.09 
      Σ MUFA-cis 211 243 9.50 0.02 21.8 23.7 0.76 0.08 
      Σ PUFA-cis  20.4 24.7 1.30 0.02 2.19 2.41 0.10 0.14 
      Σ Unknown 25.2 27.5 1.10 0.13 2.69 2.68 0.08 0.89 
Values are presented as LS Means ± SEM.  
1
Treatments were either PALM (C16:0 at 3.9% of diet DM) or control (no added fat).  
2
De novo FA originate from mammary de novo synthesis (<16 carbons), performed FA from 
extraction from plasma (>16 carbons), and both FA originate from both sources (C16:0 plus cis-
9 C16:1).  
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Table 7. Area under the curve for glucose and NEFA during glucose tolerance testing.
 
 Glucose
1
 NEFA
2
 
Time
3
 Control PALM SEM P-value Control PALM SEM P-value 
Day 0
         
60
 
6155 6640 255 0.18 3633 3752 468 0.86 
90 8290 9014 353 0.16 5472 5886 737 0.69 
120 10414 10953 386 0.33 9272 9362 1037 0.95 
150 12223 12718 457 0.44 15091 13434 1702 0.50 
180 14044 14552 486 0.46 21403 18250 2517 0.38 
Day 21         
60 6197 5992 236 0.54 2523 3362 454 0.20 
90 8371 8142 344 0.64 4053 5281 590 0.15 
120 10226 10017 367 0.68 6617 8913 1013 0.12 
150 11961 11982 436 0.97 9992 13037 1690 0.21 
180 13649 13557 463 0.65 14041 18048 2487 0.26 
Day 49         
60 6153 5660 242 0.16 2369 3823 458 0.03 
90 8402 7628 365 0.15 3770 5820 615 0.02 
120 10325 9410 388 0.10 6185 9508 1025 0.03 
150 12113 11744 436 0.56 8617 13531 1717 0.05 
180 13925 13557 477 0.58 11288 18111 2533 0.06 
1
AUC for glucose calculated using (mg/dL glucose × min). 
2
AUC for NEFA calculated using (mmol/L NEFA × min).  
3
Day relative to the start of treatment diets are denoted in bold. Subheadings reflect min relative to infusion of glucose 
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Figure 1. Palmitic acid supplementation increases milk yield and net energy intake. 
Continuous evaluation of (A) DMI (kg/d), (B) milk yield (kg/d), and (C) energy intake (Mcal/d) 
in mid-lactation cows fed PALM or control diets. Data are least squares means and their standard 
errors. *P < 0.05; †P < 0.10.   
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Figure 2. Palmitic acid supplementation acutely increases circulating NEFA and decreases 
estimated insulin sensitivity. 
Plasma concentrations of (A) NEFA, (B) insulin, and (C) glucose of mid-lactation dairy cattle 
fed control or PALM diets. (D) Estimated insulin sensitivity as measured by the revised 
quantitative insulin sensitivity check (RQUICKI), where RQUICKI was calculated as follows: 
1/[log(glucose) + log(insulin) + log(NEFA)]. Lower RQUICKI values are indicative of reduced 
insulin sensitivity. Data are least squares means and their standard errors. *P < 0.05. 
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Figure 3. Feeding cows C16:0 increases circulating cholesterol without modifying circulating 
triacylglycerol . 
Plasma concentrations of (A) TAG and (B) total cholesterol in mid-lactation cows fed control or 
PALM diets. Data are least squares means and their standard errors. *P < 0.05. 
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Minute 
Figure 4. Palmitic acid feeding does not modify glucose tolerance but reduces glucose-stimulated 
NEFA disappearance. 
Relative to the initiation of treatment, plasma concentrations of (A, C, and E) glucose and (B, D, 
and F) NEFA in control and PALM cows challenged with intravenous glucose (300 mg/kg of 
BW) on d 0, 21, and 49, respectively. Data are least squares means and their standard errors. *P 
< 0.05; †P < 0.10.
A B 
C D 
E F 
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